Skip to main content

Table 1 Adverse events recorded in Placebo-and IFNβ 1-treated subjects

From: A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects

Adverse event Placebo IFN β 1a Total
Severity Mild Moderate Mild Moderate
Articular pain 2a 0 0 0 2
Fever 0 0 1a 0 1
High cholesterol 0 0 3c 0 3
High level of ALT and AST 0 1b 0 1b 2
High pseudocholinesterase 1c 0 1c 1c 3
High triglycerides 0 0 0 1c 1
High TSH 0 1c 0 0 1
Low blood pressure 1c 0 0 0 1
Repolarization ventricular anomaly 0 0 1c 0 1
Right ear buzzing 1b 0 0 0 1
Flu-like syndrome 1c 0 0 0 1
TOTAL 6 2 6 3 17
  1. The number of adverse events in the two treatment arms is reported in details subdivided by severity degree. The relation to drug administration is shown as follows: aprobably related; bunlikely related; cunrelated. ALT, alanine aminotransferase; AST, aspartate aminotransferase; TSH, thyroid stimulating hormone.